NOVARTIS INDIA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Novartis India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.56₹ 4.40
As on Dec 24, 2025, 4:01 PM IST
Novartis India Price Performance
Today's LowToday's High
₹780.30₹789.90
₹787.25
52 Weeks' Low52 Weeks' High
₹744.95₹1,099.90
₹787.25
Open Price
₹780.30
Prev. Close
₹782.85
Volume
4,399
Over the last 5 years, the share price of Novartis India has gained 2.54% CAGR. Over the past year, the corresponding return has been -17.18%.
Novartis India’s current P/E of 18.24x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Novartis India Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Novartis India | 1.61 | -4.20 | -11.75 | -22.44 | -17.18 | 4.57 | 2.54 |
| Sun Pharmaceutical Industries | -3.21 | -2.45 | 6.80 | 4.59 | -4.41 | 20.27 | 24.12 |
| Divi's Laboratories | 3.16 | 2.12 | 8.52 | -1.10 | 12.27 | 23.69 | 11.61 |
| Torrent Pharmaceuticals | 1.66 | 3.04 | 5.99 | 20.58 | 12.65 | 34.66 | 22.45 |
| Cipla | -0.09 | -0.55 | -2.74 | -0.48 | 1.34 | 10.91 | 12.41 |
| Dr. Reddy's Laboratories | -0.32 | 3.53 | -2.41 | -5.19 | -6.16 | 14.28 | 4.03 |
| Lupin | -0.34 | 5.37 | 5.77 | 9.08 | -2.87 | 41.56 | 16.62 |
| Zydus Lifesciences | -0.10 | -0.99 | -11.37 | -4.92 | -4.87 | 29.70 | 13.38 |
| Mankind Pharma | 4.19 | -0.96 | -13.08 | -4.75 | -24.46 | 15.58 | 9.07 |
| Aurobindo Pharma | 1.42 | 1.31 | 10.86 | 9.60 | -4.14 | 40.40 | 5.89 |
| Alkem Laboratories | -1.08 | -1.09 | -0.16 | 15.83 | 2.90 | 21.81 | 13.77 |
| Abbott India | 3.45 | -3.72 | -5.10 | -9.18 | 0.54 | 9.56 | 12.70 |
| Laurus Labs | 7.56 | 10.69 | 19.40 | 62.17 | 91.40 | 41.66 | 25.52 |
| Glenmark Pharmaceuticals | 3.41 | 9.40 | -0.18 | 19.75 | 31.11 | 67.86 | 32.33 |
| Biocon | 3.02 | 0.86 | 10.92 | 14.09 | 15.44 | 14.51 | -3.75 |
| GlaxoSmithKline Pharmaceuticals | -3.94 | 0.21 | -9.76 | -23.16 | 9.49 | 23.09 | 10.09 |
| Anthem Biosciences | 0.48 | 5.66 | -18.74 | -8.61 | -8.61 | -2.95 | -1.78 |
| Ipca Laboratories | 1.11 | -0.60 | 4.56 | 5.82 | -10.75 | 18.53 | 5.49 |
| Ajanta Pharma | 4.74 | 8.33 | 7.59 | 6.14 | -2.83 | 32.00 | 19.59 |
| J B Chemicals & Pharmaceuticals | 0.89 | 3.29 | 6.77 | 0.62 | -2.99 | 23.13 | 28.52 |
Over the last one year, Novartis India has declined 17.18% compared to peers like Sun Pharmaceutical Industries (-4.41%), Divi's Laboratories (12.27%), Torrent Pharmaceuticals (12.65%). From a 5 year perspective, Novartis India has underperformed peers relative to Sun Pharmaceutical Industries (24.12%) and Divi's Laboratories (11.61%).
Novartis India Financials
Novartis India Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 780.21 | 783.67 |
| 10 | 787.77 | 786.67 |
| 20 | 795.7 | 795.69 |
| 50 | 828.72 | 824.92 |
| 100 | 874.55 | 859.72 |
| 200 | 894.65 | 892.31 |
Novartis India Share Holding Pattern
In the latest quarter, Novartis India remained same as its previous close in promoter holding, while DII stake unchanged at 0.53%, FII holding unchanged at 0.19%, and public shareholding moved up to 28.61% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Novartis India Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 25, 2025, 2:16 AM IST | Novartis - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order |
| Oct 28, 2025, 9:13 PM IST | Novartis - Integrated Unaudited Financial Results And Limited Review Report For The Quarter And Half-Year Ended September 30, |
| Oct 28, 2025, 8:35 PM IST | Novartis - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, October 28, 2025 |
| Oct 13, 2025, 9:34 PM IST | Novartis - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 30, 2025, 8:09 PM IST | Novartis - Board Meeting Intimation for Inter Alia Considering The Unaudited Financial Results For The Half Year And Quarter |
About Novartis India
Novartis India Ltd. is a Public Limited Listed company incorporated on 13/12/1947 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1947PLC006104 and registration number is 006104. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 356.27 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressInspire - BKC, 7th Floor, Mumbai Maharashtra 400051
- Contact
Management
- Mr. Christopher SnookChairperson
- Mrs. Shilpa JoshiWholeTime Director & CFO
- Mr. Falin MajmudarWhole Time Director
- Mr. Sandra MartyresIndependent Director
- Mr. Sanker ParameswaranIndependent Director
- Mr. Gira SardesaiIndependent Director
FAQs on Novartis India Share Price
What is the share price of Novartis India?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Novartis India is ₹787.25 as on Dec 24, 2025.
What kind of stock is Novartis India?
The Novartis India is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Novartis India?
The market cap of Novartis India is ₹1,943.78 Cr as on Dec 24, 2025.
What are today's High and Low prices of Novartis India?
Today’s highest and lowest price of Novartis India are ₹789.90 and ₹780.30.
What are the 52 Week High and 52 Week Low of Novartis India?
The 52-week high/low is the highest and lowest price at which Novartis India stock has traded in the past 52-week or nearly a year. The 52-week high of Novartis India is ₹1,099.90 and 52-week low of Novartis India is ₹744.95 as on Dec 24, 2025.
How has the Novartis India performed historically in terms of returns?
The Novartis India has shown returns of 0.56% over the past day, -4.2% for the past month, -11.75% over 3 months, -17.18% over 1 year, 4.57% across 3 years, and 2.54% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Novartis India?
P/E ratio of and PB ratio of Novartis India are 18.24 and 2.51 on Dec 24, 2025. While the company gives a dividend yield of 3.18 per annum.
✕
Market Pulse